JUPITER LIFE LINE HOSP L Revenue Breakdown – NSE:JLHL
NiveshIQ
NSE: JLHL · Healthcare
Jupiter Life Line Hospitals Ltd.
₹327.10▼ ₹1.20 (-0.37%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on JLHL. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Jupiter Life Line Hospitals Ltd.
Jupiter Life Line Hospitals Limited (JLHL) is a multi-specialty hospital providing healthcare services under the Jupiter brand in India. The company offers a wide range of treatments across various specialties, including bariatric surgery, cardiology, and oncology. With a strong presence in Mumbai, JLHL operates a 300-bed hospital and a 120-room hotel under the Fortune Park Lake City Hotel name. The company has been expanding its services and capacity, with plans for a major expansion announced recently. JLHL's revenue stood at ₹1408 Cr, with a net income of ₹189 Cr. The company's competitive position is strong, with a reputation for quality healthcare services. With a growth outlook driven by increasing demand for healthcare services in India, JLHL is well-positioned for future growth.
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹1,070 Cr +19.80% | ₹1,256 Cr +17.40% | ₹1,500 Cr +19.40% |
| EBITDA Margin | 24.35% | 25.33% | 25.71% |
| Net Profit | ₹176.61 Cr +142.20% | ₹193.50 Cr +9.60% | ₹199.07 Cr +2.90% |
| EPS | ₹28.44 | ₹29.47 | ₹29.59 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Jupiter Life Line Hospitals Q1 Results: Earnings call set for Aug 3
Jupiter Life Line Hospitals Ltd: షేర్ స్ప్లిట్తో సహా అన్ని తీర్మానాలకు AGM ఆమోదం!
🔒
+ 3 more stories about Jupiter Life Line Hospitals Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹388 Cr, PAT ₹49 Cr, EPS ₹7.66, EBITDA margin 25.4%. Growth context: revenue QoQ +6.1%, PAT QoQ +14.6%. Street verdict: inline, revenue surprise +1.5%, PAT surprise +5.0%.
Recent corporate activity highlights new capacity addition and capex deployment as the primary near-term growth lever, w...
FY26 (last completed FY): revenue ₹1, 500 Cr, PAT ₹199 Cr, EBITDA margin 25.7%, EPS ₹29.59. Year-on-year: revenue YoY +1...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for JLHL
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track JLHL alongside your other holdings
Unlock full JLHL research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Jupiter Life Line Hospitals Ltd.?
NiveshIQ detects active intelligence signals for Jupiter Life Line Hospitals Ltd. (JLHL) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Jupiter Life Line Hospitals Ltd.?
Jupiter Life Line Hospitals Ltd. operates in the Healthcare sector with a market capitalisation of ₹820,231.0L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.